| Withdrawn | Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety Manganese Safety in Adults | Phase 4 | 2025-02-01 |
| Withdrawn | Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-te Manganese Safety in Pediatric Patients | Phase 4 | 2024-08-01 |
| Withdrawn | Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia Iron Deficiency, Anaemia | Phase 2 | 2022-07-21 |
| Completed | Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Iron Deficiency Anemia | Phase 3 | 2019-11-19 |
| Completed | Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patient Iron Deficiency Anemia | Phase 3 | 2019-01-31 |
| Terminated | Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia Restless Legs Syndrome (RLS) | Phase 2 | 2017-07-10 |
| Completed | Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study Heart Failure, Iron-deficiency | Phase 3 | 2017-03-15 |
| Completed | Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injec Cancer and Chemotherapy Related Anemia | Phase 3 | 2015-05-23 |
| Completed | Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia Iron Deficiency, Fibromyalgia | Phase 2 | 2015-03-01 |
| Completed | A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA Iron Deficiency Anemia (IDA) | Phase 2 | 2015-02-19 |
| Withdrawn | Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopa Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | 2015-01-30 |
| Completed | Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS Restless Legs Syndrome (RLS) | Phase 3 | 2015-01-01 |
| Completed | Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease Chronic Kidney Disease | — | 2014-09-01 |
| Completed | Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Ane Iron Deficiency Anemia Secondary to IBD or Gastric Bypass | Phase 4 | 2014-01-01 |
| Completed | Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia Iron Deficiency Anemia (IDA) | — | 2013-09-01 |
| Completed | Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron Iron Deficiency Anemia (IDA) | Phase 4 | 2013-08-15 |
| Completed | Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Op Pain | Phase 3 | 2013-02-01 |
| Completed | Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Heal Methemoglobinemia, Congenital Methemoglobinemia | Phase 1 | 2012-10-01 |
| Completed | Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia | Phase 1 | 2010-11-22 |
| Completed | Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Ble Iron Deficiency Anemia | Phase 2 | 2010-09-01 |
| Completed | Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Iron Deficiency Anemia | Phase 3 | 2009-09-01 |
| Completed | Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Iron Deficiency Anemia | Phase 2 | 2009-08-01 |
| Completed | Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and I Iron Deficiency Anemia, Impaired Renal Function | Phase 3 | 2009-08-01 |
| Completed | Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Ane Anemia | Phase 3 | 2008-07-01 |
| Completed | Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia Anemia | Phase 3 | 2008-06-01 |
| Completed | Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia Anemia | Phase 3 | 2008-06-01 |
| Completed | Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects Healthy Subjects | Phase 1 | 2008-02-01 |
| Completed | Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partu Anemia | Phase 3 | 2007-10-01 |
| Completed | Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Diseas Anemia | Phase 3 | 2007-10-01 |
| Terminated | Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract Cancer of the Liver | Phase 2 | 2007-01-01 |
| Completed | Intravenous Iron Metabolism in Restless Legs Syndrome Restless Legs | Phase 2 | 2006-11-01 |
| Completed | Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients Postpartum Anemia | Phase 3 | 2006-05-01 |
| Completed | Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) Restless Legs Syndrome (RLS) | Phase 2 | 2006-03-01 |
| Completed | Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients Anemia | Phase 2 | 2006-01-01 |
| Completed | Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer Non-Small Cell Lung Cancer | Phase 3 | 2005-11-01 |
| Completed | Taxoprexin Treatment for Advanced Skin Melanoma Metastatic Melanoma | Phase 2 | 2005-10-01 |
| Completed | Taxoprexin® Treatment for Advanced Eye Melanoma Metastatic Melanoma | Phase 2 | 2005-10-01 |
| Completed | Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia Anemia | Phase 3 | 2005-07-01 |
| Completed | Safety and Efficacy of Iron Sucrose in Children Anemia, Chronic Kidney Disease | Phase 4 | 2005-07-01 |
| Completed | Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidne Anemia | Phase 3 | 2005-06-01 |
| Completed | VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Anemia | Phase 3 | 2005-05-01 |
| Completed | Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondar Anemia | Phase 3 | 2005-05-01 |
| Completed | Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia | Phase 3 | 2005-02-01 |
| Completed | Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinica Restless Legs Syndrome | Phase 2 | 2003-11-01 |
| Completed | Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia | Phase 3 | 2003-08-01 |
| Completed | Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Er Anemia | Phase 3 | 2003-02-01 |
| Terminated | Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma Malignant Melanoma | Phase 3 | 2002-12-06 |
| Completed | Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis Anemia | Phase 3 | 2002-07-01 |
| Completed | Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Ep Anemia | Phase 2 | 2002-06-05 |
| Completed | Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients Hemodialysis | Phase 4 | 2001-08-01 |
| Completed | Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis Anemia | Phase 3 | 2001-02-23 |
| Withdrawn | Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumo Iron Deficiency Anemia | Phase 4 | — |
| Completed | Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain | Phase 2 | — |